Literature DB >> 1661904

Properties and distribution of receptors for pituitary adenylate cyclase activating peptide (PACAP) in rat brain and spinal cord.

A Cauvin1, P Robberecht, P De Neef, P Gourlet, A Vandermeers, M C Vandermeers-Piret, J Christophe.   

Abstract

A high density (in the pmol/mg protein range) of specific functional receptors for PACAP (pituitary adenylate cyclase activating polypeptide) was observed in membranes from rat brain cortex, olfactory bulb, hypothalamus, hippocampus, striatum, cerebellum, pons and cervico-dorsal spinal cord, using [125I]PACAP-27 (PACAP 1-27). The tracer bound rapidly, specifically and reversibly. Competition binding curves were compatible with the coexistence, in the eight central nervous areas explored, of high and low affinity binding sites for PACAP-27 (Kd of 0.2 nM and 3.0 nM, respectively), and of only one class of binding sites for PACAP-38 (PACAP (1-38), Kd 0.2-0.9 nM). VIP inhibited only partially the binding of [125I]PACAP-27, and PHI, GRF(1-29)NH2 and secretin were ineffective at 1 microM. Chemical [125I]PACAP-27 cross-linking revealed a single specific 64 kDa protein species. In rat brain cortical membranes, saturation and competition experiments, using [125I]PACAP-38 as radioligand, indicated the presence of both high (Kd 0.13 nM) and low (Kd 8-10 nM) affinity binding sites for PACAP-38 and of low affinity (Kd 30 nM) binding sites for PACAP-27. These data taken collectively suggest the coexistence of PACAP-A receptors with a slight preference for PACAP-27 over PACAP-38 and of PACAP-B receptors that recognize PACAP-38 with a high affinity and PACAP-27 with low affinity. Both PACAP-27 and PACAP-38 stimulated adenylate cyclase with similar potency and efficacy. VIP was markedly less potent in this respect and also less efficient, except on cerebellar membranes.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1661904     DOI: 10.1016/0167-0115(91)90478-y

Source DB:  PubMed          Journal:  Regul Pept        ISSN: 0167-0115


  13 in total

1.  RANTES release contributes to the protective action of PACAP38 against sodium nitroprusside in cortical neurons.

Authors:  Alma Sanchez; Debjani Tripathy; Paula Grammas
Journal:  Neuropeptides       Date:  2009-06-03       Impact factor: 3.286

Review 2.  Pituitary adenylate cyclase-activating polypeptide receptors in the trigeminovascular system: implications for migraine.

Authors:  Tahlia Sundrum; Christopher S Walker
Journal:  Br J Pharmacol       Date:  2017-10-25       Impact factor: 8.739

3.  Specific antibody recognition of rat pituitary adenylate cyclase activating polypeptide receptors.

Authors:  M Li; S Shioda; A Somogyvári-Vigh; H Onda; A Arimura
Journal:  Endocrine       Date:  1997-10       Impact factor: 3.633

4.  Pituitary adenylate cyclase-activating polypeptide (PACAP-38) protects cerebellar granule neurons from apoptosis by activating the mitogen-activated protein kinase (MAP kinase) pathway.

Authors:  M Villalba; J Bockaert; L Journot
Journal:  J Neurosci       Date:  1997-01-01       Impact factor: 6.167

5.  PACAP38 protects rat cortical neurons against the neurotoxicity evoked by sodium nitroprusside and thrombin.

Authors:  Alma Sanchez; Haripriya Vittal Rao; Paula Grammas
Journal:  Regul Pept       Date:  2008-07-16

6.  Involvement of pituitary adenylate cyclase activating polypeptide (PACAP) and its receptors in the mechanism of antidepressant action.

Authors:  Michal Reichenstein; Moshe Rehavi; Albert Pinhasov
Journal:  J Mol Neurosci       Date:  2008-07-01       Impact factor: 3.444

Review 7.  Role of PACAP in ischemic neural death.

Authors:  Hirokazu Ohtaki; Tomoya Nakamachi; Kenji Dohi; Seiji Shioda
Journal:  J Mol Neurosci       Date:  2008-05-16       Impact factor: 3.444

8.  Pituitary adenylate cyclase-activating polypeptide (PACAP) inhibits the slow afterhyperpolarizing current sIAHP in CA1 pyramidal neurons by activating multiple signaling pathways.

Authors:  Ruth D T Taylor; Marita Grønning Madsen; Michael Krause; Marisol Sampedro-Castañeda; Martin Stocker; Paola Pedarzani
Journal:  Hippocampus       Date:  2013-09-30       Impact factor: 3.899

Review 9.  PACAP and its role in primary headaches.

Authors:  Lars Edvinsson; János Tajti; Levente Szalárdy; László Vécsei
Journal:  J Headache Pain       Date:  2018-03-09       Impact factor: 7.277

10.  Prefrontal cortex PACAP signaling: organization and role in stress regulation.

Authors:  Susan E Martelle; Evelin M Cotella; Nawshaba Nawreen; Carrie Chen; Benjamin A Packard; Maureen Fitzgerald; James P Herman
Journal:  Stress       Date:  2021-03-17       Impact factor: 3.493

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.